| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.06 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |